SCHEMBL12411447

SCHEMBL12411447

[C-]#[N+]c1cc2c(Oc3ccc(NC(=O)Nc4ccc(OC)cc4)cc3)ccnc2cc1OC

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 19/20 0.78
KDR P35968 19/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12411374 0.94 PDGFRA (0.79) PDGFRAKDR
SCHEMBL12411385 0.94 PDGFRA (0.69) PDGFRAKDR
SCHEMBL12411377 0.93 PDGFRA (0.80) PDGFRAKDR
SCHEMBL12411520 0.91 PDGFRA (0.70) PDGFRAKDR
SCHEMBL12411468 0.91 PDGFRA (0.67) PDGFRAKDR
SCHEMBL12411612 0.90 PDGFRA (0.63) PDGFRAKDR
SCHEMBL12411535 0.90 PDGFRA (0.66) PDGFRAKDR
SCHEMBL12411526 0.90 PDGFRA (0.66) PDGFRAKDR
SCHEMBL12411383 0.90 KDR (0.67) PDGFRAKDR
SCHEMBL12411381 0.90 PDGFRA (0.67) PDGFRAKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 PDGFRA 3131/4885KDR 2687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.